How High Will OXY Stock Go Now?
Occidental Petroleum (NYSE:OXY), a stock that has been made famous…
Sell
50
CTAS Quote, Financials, Valuation and Earnings
Last price:
$220.36
Seasonality move
:
4.4%
Day range:
$219.77 - $222.32
52-week range:
$172.20 - $229.24
Dividend yield:
0.71%
P/E ratio:
51.05x
P/S ratio:
8.94x
P/B ratio:
19.38x
Volume:
1.8M
Avg. volume:
1.4M
1-year change:
24%
Market cap:
$89B
Revenue:
$9.6B
EPS (TTM):
$4.32
Analysts' Opinion
-
Consensus RatingCintas has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 8 Hold ratings, and 3 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $211.11, Cintas has an estimated downside of -4.23% from its current price of $220.42.
-
Price Target UpsideAccording to analysts, the highest upside price target is $250.00 representing 13.42% upside increase from its current price of $220.42.
Fair Value
-
According to the consensus of 16 analysts, Cintas has -4.23% downside to fair value with a price target of $211.11 per share.
CTAS vs. S&P 500
-
Over the past 5 trading days, Cintas has underperformed the S&P 500 by -0.65% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cintas does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cintas has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Cintas reported revenues of $2.6B.
Earnings Growth
-
Cintas has grown year-over-year earnings for 19 quarters straight. In the most recent quarter Cintas reported earnings per share of $1.13.
Enterprise value:
91.2B
EV / Invested capital:
--
Price / LTM sales:
8.94x
EV / EBIT:
39.38x
EV / Revenue:
8.99x
PEG ratio (5yr expected):
2.66x
EV / Free cash flow:
49.94x
Price / Operating cash flow:
49.62x
Enterprise value / EBITDA:
32.53x
Gross Profit (TTM):
$5.1B
Return On Assets:
19.25%
Net Income Margin (TTM):
17.53%
Return On Equity:
41.44%
Return On Invested Capital:
26.01%
Operating Margin:
23.37%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Income Statement | ||||||
| Revenue | $8.6B | -- | $10.1B | -- | $2.6B | |
| Gross Profit | $4B | -- | $5.1B | -- | $1.3B | |
| Operating Income | $1.7B | -- | $2.3B | -- | $609.9M | |
| EBITDA | $2.1B | -- | $2.8B | -- | $738.2M | |
| Diluted EPS | $3.12 | -- | $4.32 | -- | $1.13 | |
| Period Ending | 2021-02-28 | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $2.7B | $2.9B | -- | $3.3B | |
| Total Assets | $8.3B | $8.2B | $8.5B | -- | $9.6B | |
| Current Liabilities | $1.3B | $2.6B | $1.4B | -- | $1.9B | |
| Total Liabilities | $4.5B | $4.9B | $4.8B | -- | $5B | |
| Total Equity | $3.8B | $3.3B | $3.6B | -- | $4.6B | |
| Total Debt | $2.5B | $2.9B | $2.7B | -- | $2.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.6B | -- | $2.2B | -- | $622M | |
| Cash From Investing | -$354.9M | -- | -$579.7M | -- | -$125.4M | |
| Cash From Financing | -$1.2B | -- | -$1.5B | -- | -$373.6M | |
| Free Cash Flow | $1.3B | -- | $1.8B | -- | $522.1M | |
CTAS
Sector
Market Cap
$89B
$613.1M
Price % of 52-Week High
96.15%
78.06%
Dividend Yield
0.71%
0%
Shareholder Yield
1.86%
2.29%
1-Year Price Total Return
24%
-1.3%
Beta (5-Year)
1.075
0.777
Dividend yield:
0.71%
Annualized payout:
$1.35
Payout ratio:
33.25%
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$222.29
200-day SMA
Buy
Level
$207.39
Bollinger Bands (100)
Buy
Level
198.31 - 218.83
Chaikin Money Flow
Buy
Level
931.4M
20-day SMA
Sell
Level
$224.09
Relative Strength Index (RSI14)
Sell
Level
47.94
ADX Line
Sell
Level
15.62
Williams %R
Buy
Level
-93.1362
50-day SMA
Buy
Level
$215.94
MACD (12, 26)
Buy
Level
1.43
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
611.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (12.0801)
Buy
CA Score
(Annual)
Level (0.8407)
Buy
Beneish M-Score
(Annual)
Level (-2.6852)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.6294)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cintas has roots tracing back to 1929, during which the Farmer family cleaned and re-sold dirty rags to manufacturing plants in Ohio. The firm has grown its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. In the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid, fire, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.
Stock Forecast FAQ
In the current month, CTAS has received 5 Buy ratings 8 Hold ratings, and 3 Sell ratings. The CTAS average analyst price target in the past 3 months is $211.11.
-
Where Will Cintas Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cintas share price will drop to $211.11 per share over the next 12 months.
-
What Do Analysts Say About Cintas?
Analysts are divided on their view about Cintas share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cintas is a Sell and believe this share price will rise from its current level to $163.00.
-
What Is Cintas's Price Target?
The price target for Cintas over the next 1-year time period is forecast to be $211.11 according to 16 Wall Street analysts, 5 of them rate the stock a Buy, 3 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is CTAS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cintas is a Hold. 8 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CTAS?
You can purchase shares of Cintas via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cintas shares.
-
What Is The Cintas Share Price Today?
Cintas was last trading at $220.36 per share. This represents the most recent stock quote for Cintas. Yesterday, Cintas closed at $220.42 per share.
-
How To Buy Cintas Stock Online?
In order to purchase Cintas stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Stellantis a Good Dividend Stock to Buy Right Now?
Stellantis (NYSE: STLA) isn’t the first name most income investors think of,…
Where Will Brookfield Asset Management Stock Be In 1 Year?
On a trailing basis Brookfield earned $1.60 per share over…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
83
ARQQ alert for Jun 19
Arqit Quantum [ARQQ] is up 22.6% over the past day.
Sell
47
RGC alert for Jun 19
Regencell Bioscience Holdings [RGC] is down 18.36% over the past day.
Sell
49
QNTM alert for Jun 19
Quantum BioPharma [QNTM] is up 17.61% over the past day.
